Truncated KAI1 or alternatively spliced (AS) KAI1 is associated with invasive metastasis and poor patient outcomes—except when (AS) KAI1 is expressed at low levels in human bladder cancers [1,21,55]. Here, CD82 is linked to urinary bladder carcinoma.